Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT06961604 | A Novel Method for Determination of Thromboembolic Stroke Origin | EARLY_PHASE1 | NOT YET_RECRUITING | 20 | — | — | Jun 1, 2025 | May 31, 2026 | May 8, 2025 | 1 | United States |
Can NaF PET-CT within 14 days of a non-cardiogenic thromboembolic stroke identify the likely culprit plaque as a source of the stroke
| Arm | Type | Description |
|---|---|---|
| Intervention - NaF PET | EXPERIMENTAL | Intervention/Experimental Arm - non-cardiogenic thromboembolic stroke patients to undergo NaF PET-CT |
| Name | Type | Description |
|---|---|---|
| NaF PET-CT | DRUG | Following a non-cardiogenic thromboembolic stroke, patients will undergo NaF PET-CT imaging to identify the culprit plaque and any other vulnerable plaques at high risk for rupture |
Inclusion Criteria: 18 years of age or older with a non-cardiogenic thromboembolic stroke in the past 14 days. Exclusion Criteria: Less than 18 years of age, any other kind of stroke, not clinically stable to undergo PET-CT